MENU
+Compare
CPRX
Stock ticker: NASDAQ
AS OF
Apr 2 closing price
Price
$24.46
Change
+$0.54 (+2.26%)
Capitalization
2.97B

CPRX Catalyst Pharmaceuticals Forecast, Technical & Fundamental Analysis

Catalyst Pharmaceuticals Inc is a biopharmaceutical company... Show more

CPRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for CPRX with price predictions
Apr 01, 2025

CPRX in upward trend: price rose above 50-day moving average on March 19, 2025

CPRX moved above its 50-day moving average on March 19, 2025 date and that indicates a change from a downward trend to an upward trend. In of 37 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on March 19, 2025. You may want to consider a long position or call options on CPRX as a result. In of 96 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for CPRX just turned positive on March 18, 2025. Looking at past instances where CPRX's MACD turned positive, the stock continued to rise in of 40 cases over the following month. The odds of a continued upward trend are .

The 10-day moving average for CPRX crossed bullishly above the 50-day moving average on March 25, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where CPRX advanced for three days, in of 289 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for CPRX moved out of overbought territory on March 27, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 38 similar instances where the indicator moved out of overbought territory. In of the 38 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 65 cases where CPRX's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CPRX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

CPRX broke above its upper Bollinger Band on March 20, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for CPRX entered a downward trend on March 20, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CPRX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.083) is normal, around the industry mean (13.458). P/E Ratio (18.672) is within average values for comparable stocks, (64.587). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.867). Dividend Yield (0.000) settles around the average of (0.025) among similar stocks. P/S Ratio (6.215) is also within normal values, averaging (251.391).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to slightly better than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
CPRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

CPRX is expected to report earnings to fall 51.01% to 34 cents per share on May 07

Catalyst Pharmaceuticals CPRX Stock Earnings Reports
Q1'25
Est.
$0.34
Q4'24
Beat
by $0.38
Q3'24
Beat
by $0.27
Q2'24
Beat
by $0.33
Q1'24
Beat
by $0.16
The last earnings report on February 26 showed earnings per share of 69 cents, beating the estimate of 31 cents. With 969.49K shares outstanding, the current market capitalization sits at 2.97B.
A.I. Advisor
published General Information

General Information

a developer of prescription drugs

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
355 Alhambra Circle
Phone
+1 305 420-3200
Employees
167
Web
https://www.catalystpharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RIDGX25.530.06
+0.24%
American Funds Income Fund of Amer R6
DMCYX29.17N/A
N/A
BNY Mellon Opportunistic Midcap Value Y
NWHGX14.26N/A
N/A
Nationwide Bailard Cogntv Val R6
COCVX11.75N/A
N/A
Columbia Overseas Value C
TOTTX10.93N/A
N/A
Transamerica Mid Cap Value Opps I3

CPRX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CPRX has been loosely correlated with SANA. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if CPRX jumps, then SANA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CPRX
1D Price
Change %
CPRX100%
+2.26%
SANA - CPRX
45%
Loosely correlated
+8.67%
VIR - CPRX
39%
Loosely correlated
+4.85%
CRNX - CPRX
36%
Loosely correlated
+2.51%
ATXS - CPRX
35%
Loosely correlated
+2.22%
CMPX - CPRX
35%
Loosely correlated
-24.55%
More